Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Medical and social factors of relapse development in patients with multidrug resistant tuberculosis

Elmira Berikova, Shakhmurat Ismailov, Mayra Zhaparkulova

. 2011 ; 6 (2) : 88-93.

Language English Country Czech Republic

Case-control study data of 637 multidrug resistance TB patients, successfully completed treatment course with first line anti-TB drugs plus pyrazinamide, revealed main medical and social factors of the disease recurrence. All patients were treated 4 or 5 months in clinic under standardized directly observed regimes and 18-24 months in out-patient surveillance. Relapse development was noted in 21 cases and significantly more often appeared in patients living alone and aged 30 to 40 years old.

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc14048477
003      
CZ-PrNML
005      
20141203114739.0
007      
ta
008      
140310s2011 xr d f 000 0eng||
009      
eAR
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Berikova, Elmira $u National Center for TB Problems Kazakhstan
245    10
$a Medical and social factors of relapse development in patients with multidrug resistant tuberculosis / $c Elmira Berikova, Shakhmurat Ismailov, Mayra Zhaparkulova
504    __
$a Literatura
520    9_
$a Case-control study data of 637 multidrug resistance TB patients, successfully completed treatment course with first line anti-TB drugs plus pyrazinamide, revealed main medical and social factors of the disease recurrence. All patients were treated 4 or 5 months in clinic under standardized directly observed regimes and 18-24 months in out-patient surveillance. Relapse development was noted in 21 cases and significantly more often appeared in patients living alone and aged 30 to 40 years old.
650    _2
$a společenská třída $7 D012923
650    _2
$a antituberkulotika $x terapeutické užití $7 D000995
650    12
$a multirezistentní tuberkulóza $x terapie $7 D018088
650    _2
$a výsledek terapie $7 D016896
650    _2
$a Mycobacterium tuberculosis $x účinky léků $7 D009169
650    _2
$a recidiva $7 D012008
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
653    00
$a case-control study
700    1_
$a Ismailov, Shakhmurat $u National Center for TB Problems Kazakhstan
700    1_
$a Zhaparkulova, Mayra $u National Center for TB Problems Kazakhstan
773    0_
$t Medical and health science journal $x 1804-1884 $g Roč. 6, č. 2 (2011), s. 88-93 $w MED00177704
856    41
$u http://academicpublishingplatforms.com/journal.php?journal=MHSJ $y domovská stránka časopisu - plný text volně přístupný
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140306080010 $b ABA008
991    __
$a 20141203114732 $b ABA008
999    __
$a ok $b bmc $g 1015582 $s 847032
BAS    __
$a 3 $a 4 $a PRD
BMC    __
$a 2011 $b 6 $c 2 $d 88-93 $i 1804-1884 $m Medical and Health Science Journal $n Med. Health Sci. J. $x MED00177704
LZP    __
$c NLK183 $d 20141203 $a NLK 2014-17/vt

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...